Despite medical advances around the world, individuals in Africa affected by rare diseases and pediatric cancers continue to experience disproportionate suffering. These conditions remain largely invisible within most national health strategies, leading to widespread neglect. Fewer than 10% of patients receive accurate diagnoses, and survival rates for children with rare conditions remain below 5%. The result is a generation of children and families suffering in silence, without access to the care, support, and justice they deserve.
The Rare in Africa Initiative challenges this narrative. Anchored by a $100 million funding coalition, it is a commitment to systemic change. It aims to create robust diagnostic networks, equitable care pathways, and sustainable policy reform. This is about more than healthcare. It is about transforming a global imbalance—ensuring that every child, regardless of condition or geography, has a fair chance to live, dream, and thrive.
With the world’s youngest population, a growing pool of talented scientists and clinicians, and expanding regional health networks, the continent holds untapped potential to transform how rare diseases and pediatric cancers are diagnosed and treated globally. The Rare in Africa Initiative is designed to unlock this potential by fostering collaboration across borders, sectors, and disciplines. It will build a dynamic framework that connects African research institutions with leading global centers of excellence, biotech innovators, AI and data science pioneers, and philanthropic partners. By investing directly in Africa-based research and clinical trials, the initiative will accelerate the discovery of new treatments tailored to the continent’s unique genetic and environmental contexts. It will also promote open data platforms, strengthen regulatory capacity, and support the training of a new generation of local researchers and medical professionals equipped to lead this effort. The initiative is also committed to strengthening regional hubs—Centers of Excellence in rare disease and pediatric cancer care—that will serve as beacons of hope, knowledge, and community-centered innovation. These hubs will not only advance science, but ensure that African voices, experiences, and leadership remain central to solving global health challenges.
This initiative is designed to benefit every single country in Africa. By fostering collaboration among nations, we aim to create a unified approach to tackling rare pediatric cancers and rare diseases. Each country will have access to shared resources, research findings, and best practices, ensuring that no nation is left behind in this fight. From North to South, East to West, this initiative will empower local healthcare systems, train medical professionals, and provide the tools needed to diagnose and treat rare diseases effectively.
Moreover, the initiative will establish regional hubs to ensure that even the most remote communities have access to critical information and support. By addressing these challenges collectively, we can amplify our impact, reduce disparities, and create a healthier future for all African children.
The RARE IN AFRICA Initiative is a unique opportunity for biopharmaceutical companies, research institutions, and global investors to make a lasting impact. By funding groundbreaking research and innovation in Africa, you can help unlock new treatments, improve access to life-saving therapies, and address critical healthcare gaps. Africa is a continent of immense potential, with untapped opportunities for research and development.
Your investment in the RARE IN AFRICA Initiative will not only advance scientific discovery but also ensure that children and families across the continent have access to the care they deserve. Together, we can fund clinical trials, support cutting-edge research, and bring innovative treatments to underserved populations. This is your chance to be part of a movement that transforms lives and builds a healthier future for millions. Join us in funding groundbreaking research to better understand and treat rare pediatric cancers and rare diseases.
The launch of the Rare in Africa Initiative on July 25, 2025, in Johannesburg marks more than a milestone, it marks a continental movement to transform care for people affected by rare diseases and pediatric cancers. With the world’s youngest population and a rapidly expanding health sector, Africa is poised to lead in innovation, equity, and impact. This is a defining moment to act, to invest, and to shape a future where no one is left behind because their condition is rare. The momentum is real, the leadership is in place, and the vision is bold, what’s needed now are partners who are ready to lead with purpose. Those who stand with us now will be remembered as pioneers of a generational shift in global health.
The Rare in Africa Initiative offers corporate partners unprecedented access to Africa’s fastest-growing medical market, supported by streamlined regulations, AI-driven efficiencies, and government-backed scaling. Your sponsorship unlocks exclusive branding rights across 54 nations, premium visibility at the landmark launch, and direct influence in a $200B+ emerging health economy. It is not just an opportunity to giveit is an opportunity to grow, to lead, and to leave a legacy that transcends borders.
Reach Out to Us
Call our dedicated helpline to connect with our team of experts. Whether you need guidance, resources, or emotional support, we’re here to listen and help.
Submit Your Application
Fill out our online form to share your story and needs. Our team will review your application and guide you through the next steps to access the care and support you deserve.
Stay Connected
Receive personalized updates via SMS or email. We’ll keep you informed about your application status, upcoming events, and new resources tailored to your journey.
Access Our Network
Connect with our global network of researchers, and support groups. Together, we’ll ensure you have access to the best care and innovative treatments available.
.png)
